Back to News
Market Impact: 0.35

JPMorgan raises Qualcomm stock price target to $160 on tech leadership

METAJPMQCOMUBS
Analyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsTechnology & InnovationArtificial Intelligence
JPMorgan raises Qualcomm stock price target to $160 on tech leadership

Qualcomm’s March quarter revenue was $10.6 billion, in line with expectations, but June quarter revenue guidance of $9.6 billion came in below consensus and implies a 9% sequential decline on weaker handset demand. JPMorgan raised its price target to $160 from $140 but kept a Neutral rating, citing slow diversification beyond smartphones, rising memory-price pressure in handsets, and intensifying competition in datacenter CPU/NPU markets. Other brokers were mixed, with UBS and Mizuho lifting targets to $170, BofA at $165 with Underperform, RBC at $175, and Summit Insights upgrading to Buy on AI and diversification opportunities.

Analysis

The key takeaway is not that Qualcomm is “fine,” but that the stock is running into a classic mid-cycle ceiling: earnings can look resilient while the market’s forward multiple compresses because the diversification story is not inflecting fast enough. In that setup, each incremental handset-related disappointment matters more than the headline EPS print, because it reinforces the idea that near-term cash generation is still hostage to a mature, highly cyclical end market. The result is a stock that can bounce on analyst target resets but struggles to sustain rerating without a visible step-up in non-handset revenue mix. The second-order issue is that higher memory costs are effectively a tax on the whole Android premium/supply chain, and that pressure tends to move downstream into launch pacing, channel inventories, and OEM margin defense before it shows up cleanly in unit data. That means the next few months are less about a single quarter miss and more about whether handset distributors and OEMs choose to de-risk inventories into the summer. If that happens, the earnings recovery expected later in the year can be pushed out, even if demand is not structurally broken. The AI/datacenter narrative is still real, but the bar has moved from “marketable roadmap” to “proof of durable design wins with stickier share.” In semis, the market typically gives limited credit to adjacent-market optionality until it can see at least two consecutive quarters of revenue acceleration or material gross-margin mix improvement. Until then, the most likely outcome is a stock that trades off revisions, not vision. For JPM, the interesting angle is reputational rather than directional: a mildly positive read-through on targets suggests the sell-side is still defending the franchise, but the market is increasingly forcing analysts to justify valuation with near-term execution, not strategic promises. That creates a setup where any subsequent guide-down or delayed AI commercialization can trigger a sharper de-rating than the current consensus implies. The risk window is 1-2 quarters, not 2-3 years.